Rapid Micro Biosystems (RPID) Capital Expenditures (2020 - 2026)
Rapid Micro Biosystems recorded quarterly Capital Expenditures of $394000.0 in Q1 2026, down 49.87% quarter-over-quarter from $786000.0 in Q4 2025, and up 23.51% year-over-year from $319000.0 in Q1 2025.
Rapid Micro Biosystems' Capital Expenditures history runs 7 years deep, the most recent figure standing at $394000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 23.51% year-over-year to $394000.0; the TTM figure through Mar 2026 stood at $925000.0 (down 15.83% YoY), while the FY2025 annual figure was $850000.0, down 37.73% from the prior year.
- Capital Expenditures came in at $394000.0 for Q1 2026 at Rapid Micro Biosystems, down from $786000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $5.5 million in Q3 2022 to a low of -$5.4 million in Q4 2022.
- A 5-year average of $212529.4 and a median of $319000.0 in 2025 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 498.8% in 2022 and fell as far as 860.34% in 2022.
- Rapid Micro Biosystems' Capital Expenditures stood at -$5.4 million in 2022, then surged by 104.45% to $239000.0 in 2023, then jumped by 459.41% to $1.3 million in 2024, then tumbled by 41.21% to $786000.0 in 2025, then plunged by 49.87% to $394000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $394000.0, $786000.0, and -$11000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | 394,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 394,000.00 |
| Mar 31, 2026 | 394,000.00 |
| Dec 31, 2025 | 92,000.00 |
| Dec 31, 2025 | 92,000.00 |
| Sep 30, 2025 | 683,000.00 |
| Sep 30, 2025 | 683,000.00 |
| Jun 30, 2025 | -244,000.00 |
| Jun 30, 2025 | -244,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 281,000.00 |
| Dec 31, 2024 | 281,000.00 |
| Sep 30, 2024 | -1.02 Mn |
| Sep 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | 459,000.00 |
| Jun 30, 2024 | 459,000.00 |
| Mar 31, 2024 | 585,000.00 |
| Mar 31, 2024 | 585,000.00 |
| Dec 31, 2023 | 418,000.00 |
| Dec 31, 2023 | 418,000.00 |
| Sep 30, 2023 | 453,000.00 |
| Sep 30, 2023 | 453,000.00 |
| Jun 30, 2023 | 215,000.00 |
| Jun 30, 2023 | 215,000.00 |
| Mar 31, 2023 | 759,000.00 |
| Mar 31, 2023 | 759,000.00 |
| Dec 31, 2022 | 6.73 Mn |
| Dec 31, 2022 | 6.73 Mn |
| Sep 30, 2022 | -4.33 Mn |
| Sep 30, 2022 | -4.33 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 459,000.00 |
| Sep 30, 2021 | 459,000.00 |
| Jun 30, 2021 | 541,000.00 |
| Jun 30, 2021 | 541,000.00 |
| Mar 31, 2021 | 251,000.00 |
| Mar 31, 2021 | 251,000.00 |
| Dec 31, 2020 | 265,000.00 |
| Dec 31, 2020 | 265,000.00 |
| Sep 30, 2020 | -378,000.00 |
| Sep 30, 2020 | -378,000.00 |